NCT06199882 2024-10-15SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract CarcinomaZhejiang Cancer HospitalPhase 2 Suspended34 enrolled
NCT04984980 2023-01-26Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract CancerFudan UniversityPhase 2 Unknown37 enrolled
NCT04979663 2021-08-09GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract CancerFudan UniversityPhase 1/2 Unknown10 enrolled